Brain Cancer Trial, Recruiting (NCT05464992)

Brain Cancer Trial, Recruiting NCT05464992 Sponsor: Centre Paul Strauss Condition: Brain Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05464992 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Brain Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been admitted to the Nuclear Medicine and Molecular Imaging department at ICANS (Institut de Cancérologie Strasbourg Europe) for a combined PET/MRI scan
People having this scan to assess a brain lesion before surgery
People having this scan to check whether a glioma (a type of brain tumour) has come back
People having this scan to assess brain metastases (cancer that has spread to the brain)
People having this scan to check whether brain metastases have returned

Who may not be able to join:

People for whom an MRI scan is not medically safe (for example, due to certain metal implants or other MRI-related concerns)
People under the age of 18, or adults who are under guardianship or supervision
People who are currently detained or deprived of their liberty
People who are under judicial protection (a legal protection measure)
People who are not able to give their own consent to participate
Women who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (0)368339523

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05464992

Sponsor: Centre Paul Strauss

Phase: Not Applicable

Status: Recruiting

Condition: Brain Cancer

Trial contact: (0)368339523

More information: https://clinicaltrials.gov/study/NCT05464992

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been admitted to the Nuclear Medicine and Molecular Imaging department at ICANS (Institut de Cancérologie Strasbourg Europe) for a combined PET/MRI scan
People having this scan to assess a brain lesion before surgery
People having this scan to check whether a glioma (a type of brain tumour) has come back
People having this scan to assess brain metastases (cancer that has spread to the brain)
People having this scan to check whether brain metastases have returned

Who may not be able to join:

People for whom an MRI scan is not medically safe (for example, due to certain metal implants or other MRI-related concerns)
People under the age of 18, or adults who are under guardianship or supervision
People who are currently detained or deprived of their liberty
People who are under judicial protection (a legal protection measure)
People who are not able to give their own consent to participate
Women who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Paul Strauss

Registry

ClinicalTrials.gov

Start date

28 December 2022

Est. completion

28 December 2036

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Obtention, from a set of brain PET-MRI images, of an intratissular pH mapping in patients with glioma or brain metastases; Obtention, from a set of brain PET-MRI images, of an intratissular pH mapping in patients with glioma or brain metastases

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov